thyroxine has been researched along with Cardiovascular Pregnancy Complications in 5 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "Following the diagnosis of fetal goitre at 22 and 24 weeks' gestation in two hyperthyroid pregnant women who underwent treatment with 400-500 mg of propylthiouracil in the first weeks of pregnancy, a total of seven fetal blood samplings were performed to evaluate thyroid function before and after the initiation of two different treatment regimens." | 3.69 | Prenatal treatment of fetal hypothyroidism: is there more than one option? ( Acaia, B; Beck-Peccoz, P; Cortelazzi, D; Nicolini, U; Venegoni, E, 1996) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darmochwał-Kolarz, D | 1 |
| Chara, A | 1 |
| Korzeniewski, M | 1 |
| Leszczyńska-Gorzelak, B | 1 |
| Oleszczuk, J | 1 |
| Bańkowska, EM | 1 |
| Pawłowska, A | 1 |
| Leibschang, J | 1 |
| Nicolini, U | 1 |
| Venegoni, E | 1 |
| Acaia, B | 1 |
| Cortelazzi, D | 1 |
| Beck-Peccoz, P | 1 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
| Chew, PC | 1 |
| Cheah, JS | 1 |
| Chan, LK | 1 |
| Tan, KL | 1 |
1 trial available for thyroxine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Hyperthyroidism in pregnancy: a study of 37 pregnancies in 34 patients.
Topics: Adolescent; Adult; Antithyroid Agents; Birth Weight; Female; Fetal Death; Humans; Hypertension; Hype | 1973 |
4 other studies available for thyroxine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
[Takayasu's arteritis in pregnancy--a case report].
Topics: Antihypertensive Agents; Cesarean Section; Enoxaparin; Female; Humans; Infant, Newborn; Male; Pregna | 2014 |
[Thyroid function in pregnant women with pregnancy induced hypertension].
Topics: Adult; Female; Humans; Hypertension; Hyperthyroidism; Pregnancy; Pregnancy Complications, Cardiovasc | 2003 |
Prenatal treatment of fetal hypothyroidism: is there more than one option?
Topics: Adult; Amniotic Fluid; Female; Fetal Blood; Gestational Age; Humans; Hyperthyroidism; Hypothyroidism | 1996 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |